Additional Safety Observations
- No relevant difference between bosentan and placebo in SAEs
- No relevant changes in ECG parameters or treatment-emergent ECG findings
- No relevant changes in laboratory tests except:
- Decreases in RBC parameters
- Increases in liver enzymes